- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 495/18 - Systèmes pontés
Détention brevets de la classe C07D 495/18
Brevets de cette classe: 47
Historique des publications depuis 10 ans
5
|
3
|
3
|
7
|
6
|
7
|
3
|
5
|
2
|
2
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Trustees of Columbia University in the City of New York | 3565 |
4 |
Teijin Limited | 1243 |
4 |
Fred Hutchinson Cancer Center | 441 |
4 |
Mutabilis | 27 |
3 |
University of Washington | 2322 |
3 |
Sanofi | 4040 |
3 |
Abbvie Inc. | 1805 |
2 |
Oricula Therapeutics LLC | 2 |
2 |
Rhode Island Board of Education, State of Rhode Island and Providence Plantations | 14 |
2 |
Zomagen Biosciences Ltd | 15 |
2 |
ExxonMobil Research And Engineering Company | 2579 |
1 |
Abbott Laboratories | 2403 |
1 |
FUJIFILM Corporation | 29329 |
1 |
AbbVie Deutschland GmbH & Co. KG | 263 |
1 |
Duk San Neolux Co., Ltd. | 645 |
1 |
Fred Hutchinson Cancer Research Center | 357 |
1 |
Gilead Sciences, Inc. | 2036 |
1 |
Icahn School of Medicine at Mount Sinai | 941 |
1 |
Lixte Biotechnology, Inc. | 64 |
1 |
South China Sea Institute of Oceanology, Chinese Academy of Sciences | 66 |
1 |
Autres propriétaires | 8 |